Griffin Stephen D.
Anika Therapeutics, Inc. · President and CEO
Griffin Stephen D. is listed in filings as President and CEO at Anika Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Anika Therapeutics, Inc. (ANIK). The current snapshot covers public activity from Mar 18, 2025 to Jun 5, 2026. Reported amounts are shown as $54.3K to $84.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $150k12.2k shares | BuyApr 30, 2026 | $12.29 | $15.25 |